Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jan 7, 2008; 14(1): 114-119
Published online Jan 7, 2008. doi: 10.3748/wjg.14.114
Published online Jan 7, 2008. doi: 10.3748/wjg.14.114
Table 2 Clinical characteristics of ulcerative colitis
| TG (n = 21) | CG (n = 21) | ||
| Age (yr) | 38.8 ± 10.4 | 37.1 ± 8.01 | |
| Sex | Male (%) | 16 (76.2) | 15 (71.4) |
| Female (%) | 5 (23.8) | 6 (28.6) | |
| Location | Rectum (%) | 8 (38.1) | 9 (42.9) |
| Rectosigmoid (%) | 12 (57.1) | 11 (52.4) | |
| Left colon (%) | 1 (4.8) | 1 (4.7) | |
| Type | Chronic relapse (%) | 13 (61.9) | 12 (57.1) |
| Chronic persistence (%) | 8 (38.1) | 9 (42.9) | |
| Severity | Mild (%) | 5 (23.8) | 6 (28.6) |
| Moderate (%) | 16 (76.2) | 15 (71.4) |
- Citation: Liang HL, Ouyang Q. A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitis. World J Gastroenterol 2008; 14(1): 114-119
- URL: https://www.wjgnet.com/1007-9327/full/v14/i1/114.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.114